Yüklüyor......
VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
BACKGROUND: Pulmonary Arterial Hypertension (PAH) remains a therapeutic challenge, and the search continues for more effective drugs and drug combinations. We recently reported that deletion of the vasoactive intestinal peptide (VIP) gene caused the spontaneous expression of a PH phenotype that was...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210095/ https://ncbi.nlm.nih.gov/pubmed/22029879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-141 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|